Skip to content

Company information lookup

PSIVIDA CORP. (PVA)

The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PVA 4.300 0% 4.320 4.500 0.000 0.000 0.000 0

PSIVIDA CORP. details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PVA
Securities
Official Listing Date 12 June, 2008
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.psivida.com
Registered Office Address c/- Blake Dawson, Level 37, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (08) 9443 4949
Head Office Fax (08) 9443 4949
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Dr David Mazzo (Non Exec. Chairman)
Dr Paul Ashton (President, Managing Director, CEO)
Ms Lori Freedman (Vice President, General Counsel)
Mr James Barry (Director)
Mr Douglas Godshall (Director)
Mr Michael Rogers (Director)
Mr Peter Savas (Director)
Mr Len Ross (Finance Director)
Company Secretary Ms Lori Freedman
Principal Activities The Company is the successor entity to pSivida Limited (ASX code: PVA), an ASX listed pharmaceutical and biotechnology development company which undertook a restructure by way of scheme of arrangement resulting in it becoming a wholly owned subsidiary of the Company, thereby re-domiciling to the USA.

PSIVIDA CORP. announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
06/10/2014   Disclosure Document 2 PDF
02/10/2014   Appendix 3B 13 PDF
01/10/2014   Form 8-K - US FDA approves Iluvien for DME 8 PDF
29/09/2014 asterix US FDA approves Iluvien for DME 5 PDF
26/09/2014   Form 8-K - Form 8-K - ILUVIEN - France Update 3 PDF
16/09/2014   Initial Director's Interest Notice 2 PDF
12/09/2014   pSivida files 8K with US SEC on new director 3 PDF
12/09/2014   pSivida files Form 10K 88 PDF
12/09/2014 asterix Results for Year Ended 30 June 2014 89 PDF
11/09/2014   pSivida Corp. Names James Barry to Board of Directors 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
14 Oct 2014 4.300 0% 4.300 4.200 4,850
10 Oct 2014 4.300 -8.9% 4.300 4.260 3,250
08 Oct 2014 4.720 -0.63% 4.720 4.720 1,128
07 Oct 2014 4.750 -0.42% 4.750 4.750 662
06 Oct 2014 4.770 0% 4.770 4.770 162

* Volume of shares shown represents only those shares traded on ASX.

PSIVIDA CORP. price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PVA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PVA

Warrants & Structured Products

No warrants & Structured Products are available over the security PVA